Status of selected nutrients and progression of human immunodeficiency virus type 1 infection

被引:0
|
作者
Bogden, JD
Kemp, FW
Han, SG
Li, WJ
Bruening, K
Denny, T
Oleske, JM
Lloyd, J
Baker, H
Perez, G
Kloser, P
Skurnick, J
Louria, DB
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pediat, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA
关键词
HIV-1; infection; HIV infection; AIDS; HIV progression; glutathione; magnesium; hematocrit; choline; copper; zinc; ethanol; alcohol; antioxidants;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Immune function is highly dependent on nutritional status because the large mass and high rate of cellular turnover of the immune system make it a major user of nutrients. Furthermore, nutrient requirements may be increased during acute and chronic infections, including HIV-1 infection. Objective: The current study was designed to assess relations among HIV-1 progression and 11 nutritional and demographic variables. Design: The participants were 106 HIV-infected outpatients and 29 uninfected control subjects (n = 89 men and 46 women; age range: 35-57 y). The HIV-infected subjects represented a broad range of disease progression. Results: We found lower concentrations of plasma and erythrocyte magnesium and of erythrocyte reduced glutathione beginning early in the course of HIV-1 infection. Significantly decreased hematocrit and increased serum copper concentration developed only late in the course of the disease. Statistically significant univariate associations were found between the CD4(+) T lymphocyte count and hematocrit, plasma magnesium concentration, and plasma zinc concentration. The lowest erythrocyte magnesium concentrations occurred in HIV-infected subjects who consumed alcoholic beverages. Independent variables that were significant joint predictors of CD4(+) cell count in multiple regression analyses were hematocrit and plasma free choline and zinc concentrations. These 3 factors together explained 43% of the variability in CD4(+) cell counts. Conclusion: The results provide evidence that compromised nutritional and antioxidant status begin early in the course of HIV-1 infection and may contribute to disease progression.
引用
收藏
页码:809 / 815
页数:7
相关论文
共 50 条
  • [1] Human SMOOTHENED inhibits human immunodeficiency virus type 1 infection
    Yoshida, Takeshi
    Hamano, Akiko
    Ueda, Asuka
    Takeuchi, Hiroaki
    Yamaoka, Shoji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 132 - 138
  • [2] Effectiveness of a 'hunter' virus in controlling human immunodeficiency virus type 1 infection
    Garcia-Ramos, Gisela
    Castillo, Derik
    Crowley, Philip H.
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 2513 - 2523
  • [3] Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus Type 1 Infection
    Oh, Myung Don
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (04): : 316 - 323
  • [4] Phenotype variation in human immunodeficiency virus type 1 transmission and disease progression
    Cavarelli, Mariangela
    Scarlatti, Gabriella
    DISEASE MARKERS, 2009, 27 (3-4) : 121 - 136
  • [5] SERUM FACTORS IN THE PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION TO AIDS
    TOMAR, RH
    HENNIG, AK
    OATES, RP
    YUILLE, MAR
    JOHN, PA
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1990, 4 (03) : 218 - 223
  • [6] Enhancing immune restoration in human immunodeficiency virus infection
    Sahali, S.
    Carcelain, G.
    Goujard, C.
    Delfraissy, J. -F.
    Ghosn, J.
    REVUE DE MEDECINE INTERNE, 2011, 32 (07): : 425 - 431
  • [7] The role of IL-1β during human immunodeficiency virus type 1 infection
    Yaseen, Mahmoud M.
    Abuharfeil, Nizar M.
    Darmani, Homa
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (01)
  • [8] Human immunodeficiency virus type 1 infection, clinical trials and ethics in paediatrics
    deMartino, M
    Galli, L
    Amato, AG
    Vierucci, A
    ACTA PAEDIATRICA, 1997, 86 : 78 - 85
  • [9] Primary human immunodeficiency virus type 1 infection in a patient with acute rhabdomyolysis
    McDonagh, CA
    Holman, RP
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (10) : 1027 - 1030
  • [10] Molecular monitoring of human immunodeficiency virus type 1 infection
    Clementi, M
    Bagnarelli, P
    Menzo, S
    Cardelli, M
    Mazzola, F
    Sampaolesi, R
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1997, 11 (1-2) : 64 - 68